<DOC>
	<DOCNO>NCT00641147</DOCNO>
	<brief_summary>This randomized phase II trial study curcumin treat patient familial adenomatous polyposis . Curcumin may prevent colorectal cancer patient history rectal polyp colorectal neoplasia .</brief_summary>
	<brief_title>Curcumin Treating Patients With Familial Adenomatous Polyposis</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine randomize , double-blinded , placebo-controlled study tolerability effectiveness curcumin regress intestinal adenoma measure duodenal colorectal/ileal polyp number , polyp size familial adenomatous polyposis patient intact colon , ileorectal anastomosis surgery , ileo-anal pullthrough ( reservoir ) surgery . II . To measure marker cell proliferation include colorectal mucosal level ornithine decarboxylase ( ODC ) , polyamines , mucosal deoxyribonucleic acid ( DNA ) methylation , proliferative index ( Ki67 antiproliferative cell nuclear antibody ) , apoptosis index , vascular density , mucosal prostaglandin , leukotriene level , activation nuclear factor kappa B ( NFKB ) , v-akt murine thymoma viral oncogene homolog 1 ( Akt ) survival pathway . OUTLINE : Patients randomize 1 2 treatment arm . ARM I : Patients receive curcumin orally ( PO ) twice daily ( BID ) 12 month . ARM II : Patients receive placebo PO BID 12 month . After completion study treatment , patient follow 4 month .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Adenomatous Polyposis Coli</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>Patients familial adenomatous polyposis undergone subtotal colectomy ileorectal anastomosis , total coloctomy ileoanal pull ( reservoir ) , patient intact colon 5 adenoma rectumsigmoid reservoir Patients familial adenomatous polyposis ( FAP ) duodenal adenomatous polyposis without current low tract adenomatous polyposis i.e . status/post ( s/p ) ileostomy Female patient childbearing age effective birth control Pregnant woman White blood cell count ( WBC ) &lt; 3500/ml Platelet count &lt; 100,000/ml Blood urea nitrogen ( BUN ) &gt; 25mg % Creatinine &gt; 1.5mg % Patients unable stop nonsteroidal antiinflammatory drug ( NSAIDs ) , aspirin , curcumin , tumeric , calcium , vitamin D , green tea , polyphenol E supplement duration trial Malignancy nonmelanoma skin cancer Active bacterial infection Patients symptom active gastroesophageal reflux disease ( GERD ) ( symptomatic despite medication current erosive esophagitis endoscopy ) Patients history peptic ulcer disease Patients warfarin plavix</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>